By Pete Brown, College of Engineering | November 4, 2013
Retinal implants have not lived up to their potential, argues a joint UA-German research team, until now.Continue reading
By Pete Brown, College of Engineering | November 4, 2013
Retinal implants have not lived up to their potential, argues a joint UA-German research team, until now.Continue reading
Renowned Surgeon Francisco Arabia Discusses His Experience with Implantation of Over 100 SynCardia Total Artificial Hearts as it Relates to INTERMACS StatisticsContinue reading
On November 4, 2013, the Arizona Commerce Authority (ACA) announced its 25 semifinalists in the Fall 2013 Arizona Innovation Challenge (AIC), a bi-annual business plan competition that awards the most money in the country for a technology commercialization challenge.Continue reading
Ten Arizona Legislators Named AZBio Trailblazers By The Arizona Bioindustry Association In Recognition Of Their Leadership And Actions In Support Of The Advancement Of Arizona’s Life Science And Healthcare Industry.Continue reading
Celebration Stem Cell Centre, an AABB accredited and FDA registered public and private cord blood bank located in Gilbert, AZ is actively seeking a Medical Director.
Candidates must be a licensed physician that is qualified by training or experience in bone marrow and cord blood transplantation. The Medical Director shall have responsibility and authority for all medical activities related to procurement, processing, and provision of the cellular therapy products and related services and to ensure that these activities are compliant with AABB, FDA and NMDP requirements. The Medical Director will work closely with the current Laboratory Director and Quality Director in respect to the following responsibilities:
All qualified individuals are encouraged to apply for this position. Please send a copy of your C.V. and cover letter to info@csccaz.com.
PALMS study finds dual-biomarker test to be highly sensitive and specific for cervical precancersContinue reading
FDA Approves Gazyva™ (Obinutuzumab) for People With Previously Untreated Chronic Lymphocytic Leukemia (CLL)Continue reading
The Arizona Center for Innovation (AzCI) is pleased to announce that the Flinn Foundation has selected MSDx, Inc. to receive grant funding and program services through the Foundation’s 2013 Bioscience Entrepreneurship Program. MSDx is a personalized medicine diagnostics company developing blood test products for monitoring disease activity in neurological disorders such as Multiple Sclerosis (MS). The Foundation funding will be used to support further development of the MSDx blood testing technology.
The Small Business Innovation Research & Small Business Technology Transfer (SBIR & STTR) Programs are government set-aside programs that represent one of the largest sources of early-stage technology financing in the United States. The National Cancer Institute (NCI) SBIR/STTR Programs are designed to catalyze the development of innovative technologies and therapeutics to advance cancer research, prevention, detection, and treatment.
In FY2014, the set-asides reserved for small businesses have increased from 2.5% to 2.7% for SBIR and 0.35% to 0.40% for STTR. Please note the budget caps for the specific funding opportunity you are applying for, as they cannot be exceeded. We encourage you to review the opportunities below and consider applying for funding to the NCI SBIR & STTR Programs. NCI SBIR Development Center Program Directors are available to discuss ideas and opportunities with you. |
||||||
|
||||||
|
||||||
|
||||||
|
||||||
|
||||||
How to Apply For resources and tips for applying, please click here. Please visit http://sbir.cancer.gov/ to learn more about the NCI SBIR & STTR Programs. |